2019 American Transplant Congress
Use of Opioids and NSAIDs in Living Kidney Donors: Clinical Correlates and Early Outcomes
*Purpose: Data are limited regarding pain medication use in living kidney donors (LKD). Concerns relate to opioid use, and to non-steroidal anti-inflammatory (NSAID) use in…2019 American Transplant Congress
Proximal Splenic Artery Embolization For Refractory Ascites And Hydrothorax After Liver Transplant: A Single Center Analysis Of Factors Associated With Success
Cleveland Clinic, Cleveland, OH
*Purpose: The aims of this study were to (1) assess the efficacy of proximal SAE for the treatment of RA and RH caused by portal…2019 American Transplant Congress
Effect of Human Leukocytic Antigen Matching on Clinical Outcomes after Deceased Donor Renal Allograft Transplant: A Single Centre Experience
*Purpose: Human leucocyte antigen (HLA) matching has been the cornerstone of kidney allocation policies. With increasing expertise in assessing and managing immunological risks, the impact…2019 American Transplant Congress
Kidney Function Evaluation Among Living Donors In A Multiracial Population. The Results From A Brazilian Single-center Cohort Study.
Hospital Israelita Albert Einstein, São Paulo, Brazil
*Purpose: to assess renal function among living kidney donors in Brazil, where the population is greatly race-mixed.*Methods: This is a retrospective single-center cohort study involving…2019 American Transplant Congress
Vaccine Response as a Predictor of Kidney Transplant Rejection and Serious Infection
Department of Nephrology, Monash Health, Clayton, Australia
*Purpose: Vaccination generates immune memory, including antibodies against harmful pathogens. Transplant immunosuppression prevents similar processes occurring against alloantigens. Transplant recipients have significantly reduced seroresponses to…2019 American Transplant Congress
Long Term Outcomes in Kidney Transplant Recipients Receiving Everolimus (EVR) or Mycophenolate (MPS) in Combination with Tacrolimus (TAC)
Hospital do Rim, Nephrology Division, EPM - UNIFESP, São Paulo, Brazil
*Purpose: Detailed long-term data comparing the use of EVR or MPS in kidney transplant recipients receiving TAC is lacking.*Methods: This is a 5-years extension analysis…2019 American Transplant Congress
Deficiency of IRE1a Ameliorates Renal Allograft Injury via Remodeling of Graft-Infiltrating Macrophages
*Purpose: Inflammatory macrophages contribute to the development of ischemia-reperfusion injury (IRI) and allograft rejection. However, the underlying mechanisms by which macrophage mediate allograft injury and…2019 American Transplant Congress
Renal Recovery and Prognostic Factors in Children Following Liver Transplantation
Department of Pediatrics II, University Hospital Essen, Essen, Germany
*Purpose: Progression to chronic renal disease (CKD) is highly prevalent in adults following liver transplantation (LT) with a profound impact on patient survival, assuming that…2019 American Transplant Congress
Belatacept Use in High Kidney Donor Profile Index Kidney Transplant Recipients
1Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, 2Veloxis Pharmaceuticals, Cary, NC
*Purpose: To determine whether the use of belatacept is associated with renal function preservation in kidney transplant recipients from donors with a kidney donor profile…2019 American Transplant Congress
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast Enhanced Ultrasonography
*Purpose: To evaluated the application of contrast enhanced ultrasonography (CEUS) in diagnosis of renal allograft chronic rejection (CR).*Methods: Sixty-six renal transplantation recipients were enrolled in…
American Transplant Congress abstracts